stockportfolio.pro
Indivior Pharmaceuticals, Inc. Total Debt 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $290.00M | -7.9% |
| FY 2024 | $315.00M | +32.9% |
| FY 2023 | $237.00M | — |
| FY 2022 | $0 | — |
Source: Indivior Pharmaceuticals, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Indivior Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIndivior Pharmaceuticals, Inc. — frequently asked questions
What is Indivior Pharmaceuticals, Inc.'s total debt (short- plus long-term borrowings)?
Indivior Pharmaceuticals, Inc. (INDV) reported total debt (short- plus long-term borrowings) of $290.00M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Indivior Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.